NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report

Show other versions (1)

Background: NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants are hetero...

Full description

Bibliographic Details
Main Authors: Abdul Rashid, A.M (Author), Baharin, J. (Author), Basri, H. (Author), Hanapiah, F.A (Author), Hoo, F.K (Author), Ibrahim, A. (Author), Inche Mat, L.N (Author), Loh, W.C (Author), Md Noh, M.S.F (Author), Wan Sulaiman, W.A (Author), Yusof Khan, A.H.K (Author)
Format: Article
Language:English
Published: Springer Science and Business Media Deutschland GmbH 2021
Series:Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Subjects:
acute kidney failure
aged
alanine aminotransferase
albumin
amikacin
anticoagulant agent
apixaban
Article
aspartate aminotransferase
atorvastatin
beta adrenergic receptor blocking agent
bilirubin
bisoprolol
blood pressure
brain stem
C reactive protein
cardioembolic stroke
case report
cefepime
Chinese traditional medication
clinical article
cloxacillin
computer assisted tomography
creatinine
echography
Elderly
electrocardiogram
excision
hemoglobin
Hepatotoxicity
human
hydroxymethylglutaryl coenzyme A reductase inhibitor
ischemic stroke
leukocyte count
liver cyst
liver toxicity
magnetic resonance angiography
male
National Institutes of Health Stroke Scale
NeuroAid II
pantoprazole
piperacillin plus tazobactam
polypharmacy
pulse rate
Stroke
sultamicillin
thrombocyte
unclassified drug
urea
Online Access:View Fulltext in Publisher
View in Scopus

Internet

View Fulltext in Publisher
View in Scopus

Similar Items